Table 2.
Correlations of CT-proET-1 with clinical scores and other laboratory markers
| All patients | ||
|---|---|---|
| r | p | |
| Markers of inflammation | ||
| CRP | 0.416 | <0.001 |
| Procalcitonin | 0.343 | 0.005 |
| IL6 | 0.172 | 0.027 |
| Markers of organ dysfunction | ||
| Cystatin C | 0.624 | <0.001 |
| GFR | −0.534 | <0.001 |
| ALT | −0.165 | 0.016 |
| Bilirubin | 0.148 | 0.031 |
| Prothrombin time | −0.220 | 0.001 |
| Albumin | −0.321 | <0.001 |
| Urea | 0.577 | <0.001 |
| NTproBNP | 0.505 | <0.001 |
| Clinical scores | ||
| APACHE-II | 0.239 | 0.001 |
| SOFA | 0.136 | n.s. |
| SAPS 2 | 0.400 | <0.001 |
| New and experimental biomarkers | ||
| Resistin | 0.449 | <0.001 |
| NTproCNP | 0.604 | <0.001 |
| suPAR | 0.529 | <0.001 |
Abbreviations: ALT alanine aminotransferase, APACHE Acute Physiology and Chronic Health Evaluation, ALT alanine aminotransferase, CRP C-reactive protein, GFR glomerular filtration rate, IL6 interleukin 6, NTproBNP amino-terminal propeptide of brain natriuretic peptide, NTproCNP, amino-terminal propeptide of C-type natriuretic peptide, SAPS Simplified Acute Physiology Score, SOFA sequential organ failure assessment, suPAR soluble urokinase plasminogen activator receptor, n.s. not significant